Pneumonia vaccine study for healthy children
Part of Infections clinical trials.
This study tests a new pneumonia vaccine in healthy children to see if it is safe and works well. It may help protect your child from serious infections caused by the bacteria that lead to pneumonia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 2 and 5 years old
- Your child must be generally healthy (no serious ongoing illnesses)
- Your child has not received any pneumonia vaccine before
- Your child has not had a confirmed pneumonia infection before
- Your child must be available for all study visits and vaccinations
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new pneumococcal vaccine for babies around 2 months old. It aims to prevent serious infections like pneumonia and meningitis, and may offer protection against more strains than current vaccines.
This trial tests a 13-valent pneumococcal conjugate vaccine to prevent pneumonia and serious infections caused by pneumococcus bacteria. It may be a good option if your child has never had a pneumococcal vaccine before.
This trial tests a new pneumococcal vaccine (PCV24) in healthy infants and children. It aims to protect against serious infections like pneumonia and meningitis caused by pneumococcal bacteria.
This study tests a new pneumonia vaccine (PCV13) in healthy infants to see if it works as well as a current vaccine. It compares the immune response and safety of the two vaccines.
This study tests a new pneumococcal vaccine (PCV24) for babies ages 2 to 23 months. It aims to see if the vaccine is safe and helps protect against serious infections like pneumonia and meningitis.
This study tests a new vaccine that protects against 21 types of bacteria that cause pneumonia and other infections. It is for healthy infants around 2 months old to see if it works as well as the current vaccine.
Hear when a new Pneumococcal Infectious Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.